To assess renal biomarkers in diabetic and non-diabetic patients attending the secondary-level hospital of district Attock | [Rawal Medical Journal • 2024]

Author(s):

1. Aimal Khan: Department of Endocrinology and Diabetes, Shifa International Hospital, Islamabad, Pakistan

2. Syed Zakir Shah: Department of Medicine, Shifa International Hospital, Islamabad, Pakistan

3. Amna Ihsan: Department of Biochemistry, King Edward Medical University Lahore, Pakistan

4. Jahangir Zaib: Department of Medicine, Poonch Medical College, Rawalakot, Pakistan

5. Nasim Ilyas: Department of Biochemistry, Bahawalpur Medical College, Bahawalpur, Pakistan

6. Ahmed Albalooshi: Department of Physiology, Rai Medical College, Sargodha, Pakistan

Abstract:

Objective: To assess renal biomarkers in diabetic and non-diabetic patients attending the secondary-level hospital of district Attock, Pakistan. Methodology: This prospective study was conducted in a secondary-level hospital of district Attock from 02-01-2023 to 30-6-2023. A total of 100 subjects were enrolled voluntarily using convenient sampling. They were divided in two groups; group A with diabetes and group B without any illness. Vitals, BSR, HBA1C, cystatin C, creatinine, and urea were recorded. Data were analyzed using MS Excel. Results: Group A had 27 females, 22 males, and 1 transgender. 33% had good glycemic control as shown by HBA1C and 15% had poor glycemic control and derangement of urea, creatinine, and cystatin c. 11% had poor glycemic control and raised levels of cystatin C but normal urea and creatinine levels. Group B had 37 females and 13 males. 4% had derangement of all three renal biomarkers and another 5% had raised levels of cystatin C. 28% had hypertension, 12% had COPD, 6% had depressive illness, 54% had no chronic illness. Conclusion: Cystatin C showed promising results in the early detection of renal damage in diabetic patients compared with creatinine and urea. However, the only drawback is the high cost of testing for cystatin C. Considering the long-term benefits of avoiding complications would be much more beneficial despite the higher cost.

Page(s): 1-3

DOI: DOI not available

Published: Journal: Rawal Medical Journal, Volume: 49, Issue: 1, Year: 2024

Keywords:

Diabetes Mellitus , Diabetes Mellitus , Nephropathy , noncommunicable disease , renal biomarkers , and neuropathy

References:

[1] .2006 .Diagnosis and classification of diabetes mellitus. Diabetes Care, 29(1) : S43-8.

[2] Shlomo M,Polonsky KS,Larsen PR,Kronenberg HM. Diabetes,Mellitus HM. Diabetes .2011 .Willams textbook of endocrinology. , 18 : 1371-1435.

[3] .2023 .. Diabetes [Internet]. World Health Organisation, : .

[4] Khan MAB,Hashim MJ,King JK,Govender RD,Mustafa H,Al Kaabi H .2020 .. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health, 10(1) : 107-111.

[5] Basit A,Askari S,Zafar J,Riaz M,Fawwad A .2021 .Prevalence and risk factors for obesity in urban and rural areas of Pakistan: a study from second National Diabetes Survey of Pakistan (NDSP. Obes Res Clin Pract, 15(1) : 19-25.

[6] Abdal Hassan . .. 2023 [cited 2023 Dec, 27 : .

[7] Khilat F,Tariq F,Malik S.,Enhancing Tourism S. .2021 .Potential: A Revitalizing Plan for Central Zone of Hassanabdal Town. Global Soc Sci Rev, 4(4) : 27-46.

[8] Shen ZZ,Huang YY,Hsieh CJ .2017 .Early short-term intensive multidisciplinary diabetes care: A ten-year follow-up of outcomes. Diabetes Res Clin Pract, 130 : 133-141.

[9] McGill M,Blonde L,Chan JCN,Khunti K,Lavalle FJ,Bailey CJ .2017 .Global Partnership for Effective Diabetes Management. The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios. J Clin Transl Endocrinol, 7 : 21-27.

[10] Whaley A,Sowers JR,McCullough PA,Roberts T,Mcfarlane SI,Chen SC .2009 .Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis, 53(4) : S11-21.

[11] Cheng C,Liu Y,Sun X,Yin Z,Li H,Zhang M .2019 .Doseresponse association between the triglycerides: High-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: The rural Chinese cohort study and meta-analysis. J Diabetes, 11(3) : 183-92.

[12] Sirivole MR,Eturi S. .2017 .A study on blood urea and serum creatinine in diabetes mellitus from Sangareddy District. Int J Med Health Res, 3(12) : 132-6.

[13] Anjaneyulu M .2004 .Chopra K. Quercetin, an antioxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol, 31(4) : 244-8.

[14] Amartey N,Nsiah K .2015 .Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab. J Clin Diagn Res, 9(2) : 5-9.

[15] Abdulrahman .2017 .A. Prevalence of diabetic nephropathy among type 2 diabetic patients in some of the Arab countries. Int J Health Sci, 11(1) : 1-4.

[16] Biri SRK,Sankeerthi C,Rani T,Gundu R,Vadlakonda A .2021 .A study on evaluating blood urea and serum creatinine in diabetes mellitus patients. Int J Clin Biochem Res, 8(4) : 285-288.

[17] Chutani A,Pande S. .2017 .Correlation of serum creatinine and urea with glycaemic index and duration of diabetes in Type 1 and Type 2 diabetes mellitus: A comparative study. Nat J Physiol, 7 : 914-919.

[18] Willey JZ,Moon YP,Husain SA,Elkind MSV,Sacco RL,Wolf M . .Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. 2020 Jan, 15(1) : e0226509.

[19] Kumaresan R,Giri P. .2011 .A comparison of serum cystatin C and creatinine with glomerular filtration rate in Indian patients with chronic kidney disease. Oman Med, 26(6) : 421-5.

[20] Elsayed MS,El Badawy A,Ahmed A,Omar R,Mohamed A .2019 .Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Syndr, 13(1) : 374-381.

Citations

Downloads

Views